Niki BioSolutions (NIKI) vs ReTo Eco-Solutions (RETO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Niki BioSolutions (NIKI) has outperformed ReTo Eco-Solutions (RETO) over the past year, losing 82.1% versus a loss of 99.7%. Over five years, NIKI leads with a -98.3% price change compared with -100.0% for RETO. Niki BioSolutions is the larger company by market cap ($12.5 million vs $3.1 million), about 4.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NIKI | RETO |
|---|---|---|
| Share price | $4.00 | $1.32 |
| Market cap | $12.47M | $3.13M |
| 1-day change | -7.41% | -5.71% |
| YTD return | -59.25% | -99.08% |
| 1-year return | -82.07% | -99.71% |
| 5-year return | -98.33% | -100.00% |
| EPS (TTM) | $-2.90 | $-2,067.20 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $24.00 | $472.00 |
| 52-week low | $4.00 | $1.32 |
| Distance from 52-week high | -83.33% | -99.72% |
| Average volume | 157.52K | 1.87M |
| Shares outstanding | 2.94M | 2.32M |
| Employees | 1 | 48 |
| Sector | Industrials | Industrials |
| Industry | Industrial Machinery/Components | Industrial Machinery/Components |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Niki BioSolutions is about 4.0 times larger than ReTo Eco-Solutions by market value ($12.47M vs $3.13M).
- NIKI has outperformed RETO by 17.6 percentage points over the past year.
About Niki BioSolutions
NIKI stock →Niki BioSolutions, Inc., through its subsidiaries, operates as a clinical-stage biopharmaceutical company and engages in the discovery, development, and commercialization of therapeutic products to treat oncology and infectious diseases. Its pipeline products include SACT-1, a repurposed drug candidate, which is in a Phase 1 clinical trial to treat neuroblastoma and other cancer types; ALS-4, a repurposed small molecule, which is in a Phase 1 clinical trial for the treatment of bacterial infections, such as staphylococcus aureus, mycobacterium tuberculosis, and pseudomonas aeruginosa.
Industrials · Industrial Machinery/Components · 1 employees
About ReTo Eco-Solutions
RETO stock →ReTo Eco-Solutions, Inc. focuses to design, research and development, manufactures, and sale of ecological environmental protection equipment and intelligent equipment in China, the Middle East, India, Malaysia, Africa, Maldives.
Industrials · Industrial Machinery/Components · 48 employees
NIKI vs RETO FAQ
Which is bigger, Niki BioSolutions or ReTo Eco-Solutions?
Niki BioSolutions (NIKI) is larger, with a market capitalization of $12.47M compared with $3.13M for ReTo Eco-Solutions (RETO).
Which stock has performed better over the past year, NIKI or RETO?
NIKI returned -82.07% over the past 12 months, compared with -99.71% for RETO (price return, excluding dividends). Past performance does not predict future results.
Are Niki BioSolutions and ReTo Eco-Solutions in the same industry?
Yes. Both are classified in the Industrial Machinery/Components industry within the Industrials sector.